Rossari Biotech Ltd (ROSSARI) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543213 | NSE: ROSSARI | Chemicals | Small Cap

Rossari Biotech Share Price

602.05 1.05 0.17%
as on 05-Dec'25 11:54

Rossari Biotech Ltd (ROSSARI) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543213 | NSE: ROSSARI | Chemicals | Small Cap

DeciZen - make an informed investing decision on Rossari Biotech

Overall Rating
Bole Toh

1. Quality

2. Valuation

Undervalued

3. Price Trend

Rossari Biotech stock performance -

Key Ratios
mw4me loader
P/E Ratio (CD):
24.36
Market Cap:
3,328.4 Cr.
52-wk low:
568.1
52-wk high:
883

Is Rossari Biotech Ltd an attractive stock to invest in?

1. Is Rossari Biotech Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Rossari Biotech Ltd is a good quality company.

2. Is Rossari Biotech Ltd undervalued or overvalued?

The key valuation ratios of Rossari Biotech Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Rossari Biotech Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Rossari Biotech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Rossari Biotech:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Rossari Biotech Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 10.3%26.4%40.4%54.4%37.9%28.8%24.4%18.5%18.4%16.1%-
Value Creation
Index
-0.30.91.92.91.71.10.80.30.30.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 1792332925166007091,4831,6561,8312,0802,222
Sales YoY Gr.-30.6%25%76.9%16.3%18.2%109.1%11.7%10.6%13.6%-
Adj EPS 0.73.35.99.512.615.316.318.322.623.324.7
YoY Gr.-364.3%81.9%60.1%33.1%21.8%6%12.9%23.1%3.1%-
BVPS (₹) 10.313.519.525.656.478.3145.7165.3189213.7226
Adj Net
Profit
3.415.728.645.863.979.689.5101125129137
Cash Flow from Ops. 25.77.223.671.256.847.829.415243.3137-
Debt/CF from Ops. 0.93.10.90.11.200.30.52.51.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 31.4%28.2%11.9%13.6%
Adj EPS 47.6%13.1%12.7%3.1%
BVPS40%30.5%13.6%13.1%
Share Price - -6.3% -9.7% -26.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
727.335.84231.122.914.711.812.711.511.2
Op. Profit
Mgn %
710.415.315.117.517.411.91313.312.212.3
Net Profit
Mgn %
1.96.79.88.910.711.266.16.86.26.2
Debt to
Equity
0.50.30.200.2000.10.10.20.1
Working Cap
Days
13210710910714016313416618921183
Cash Conv.
Cycle
6242452413294668798438

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 11.94%

Net Profit is growing at healthy rate in last 3 years 12.71%

Sales growth is good in last 4 quarters at 15.45%

Return on Equity has declined versus last 3 years average to 11.20%

Latest Financials - Rossari Biotech Ltd.

Standalone Consolidated
TTM EPS (₹) 21.8 24.7
TTM Sales (₹ Cr.) 1,580 2,222
BVPS (₹.) 204.1 226
Reserves (₹ Cr.) 1,119 1,240
P/BV 2.94 2.66
PE 27.63 24.36
From the Market
52 Week Low / High (₹) 568.05 / 883.00
All Time Low / High (₹) 536.10 / 1620.60
Market Cap (₹ Cr.) 3,328
Equity (₹ Cr.) 11.1
Face Value (₹) 2
Industry PE 48.1

Management X-Ray of Rossari Biotech:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Rossari Biotech - Consolidated Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Rossari Biotech

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales1792332925166007091,4831,6561,8312,080
Operating Expenses 1662092474394955861,3071,4411,5871,826
Manufacturing Costs46313142138496477
Material Costs1311661973393724621,1081,1711,2941,433
Employee Cost 1214202837426899103132
Other Costs 20232859736193123127184
Operating Profit 13244578105123176215243254
Operating Profit Margin (%) 7.0%10.4%15.3%15.0%17.5%17.3%11.9%13.0%13.3%12.2%
Other Income 01114919141415
Interest 42134313221918
Depreciation 54512172348636067
Exceptional Items 0000000000
Profit Before Tax 519406388107136144178185
Tax 131118232739374749
Profit After Tax 3162946658098107131136
PAT Margin (%) 1.9%6.7%9.9%8.8%10.9%11.3%6.6%6.5%7.1%6.6%
Adjusted EPS (₹)0.73.36.09.412.915.517.719.523.724.6
Dividend Payout Ratio (%)0%0%30%5%4%3%3%3%2%2%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 5065941242864078029121,0441,183
Share Capital 4444101011111111
Reserves 4661901192763967919011,0331,172
Minority Interest0000000000
Debt222220461006496186
Long Term Debt721134003533100
Short Term Debt15201932700296386
Trade Payables28324010697131186181219286
Others Liabilities 85114980107429415465532
Total Liabilities 1091241662835256451,4171,5721,8252,187

Fixed Assets

Gross Block38768886122234704743791878
Accumulated Depreciation0384312295397158213279
Net Fixed Assets 3838457494181607585578598
CWIP 8810322011647140
Investments 007018036516384
Inventories252435555895190188282355
Trade Receivables3147608694144305354425475
Cash Equivalents 321612788521243057
Others Assets 55859112135225253399478
Total Assets 1091241662835256451,4171,5721,8252,187

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 267247157482915243137
PBT 519406388107136144178185
Adjustment 76617202155837684
Changes in Working Capital 13-14-1111-31-48-112-28-157-73
Tax Paid -1-3-11-20-20-31-50-48-54-59
Cash Flow From Investing Activity -5-6-20-36-190-37-299-181-103-184
Capex -5-6-14-44-76-56-36-31-126-158
Net Investments 0007-1814-6-14-9-18
Others 00-71-965-257-13632-7
Cash Flow From Financing Activity -19-2-5-29157-25292611665
Net Proceeds from Shares 000010043302445
Net Proceeds from Borrowing 000-139-34045-1255
Interest Paid -3-2-1-2-3-4-2-6-16-17
Dividend Paid 000-11-3-3-3-3-3-3
Others -17-0-4-1624-27-5214324
Net Cash Flow 2-0-2623-142232-4419

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)6.9927.2736.3341.8831.8323.1116.1712.5213.3612.25
ROCE (%)10.326.440.3754.437.9328.8124.3718.4818.3916.07
Asset Turnover Ratio1.622.062.31.491.221.451.111.081.04
PAT to CFO Conversion(x)8.670.440.831.540.880.60.31.420.331.01
Working Capital Days
Receivable Days62616651546155727779
Inventory Days58383632343935424756
Payable Days656667791009052575664

Rossari Biotech Ltd Stock News

Rossari Biotech Ltd FAQs

The current trading price of Rossari Biotech on 05-Dec-2025 11:54 is ₹602.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Rossari Biotech stood at ₹3,328.4.
The latest P/E ratio of Rossari Biotech as of 04-Dec-2025 is 27.63.
The latest P/B ratio of Rossari Biotech as of 04-Dec-2025 is 2.94.
The 52-week high of Rossari Biotech is ₹883.0 and the 52-week low is ₹568.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Rossari Biotech is ₹1,580 ( Cr.) .

About Rossari Biotech Ltd

The company was initially incorporated as Rossari Labtech on March 6, 2003, as a partnership firm under the Indian Partnership Act, 1932, pursuant to a certificate of registration dated June 22, 2003, issued by the Registrar of Firms, Mumbai. The name of the partnership firm was changed to Rossari Biotech on December 5, 2003 and further the firm converted into a joint stock company on August 10, 2009, under part IX of the Companies Act, 1956 as Rossari Biotech Limited with a certificate of incorporation granted by the Registrar of Companies, Maharashtra at Mumbai (RoC). The company received its certificate of commencement of business on August 13, 2009.

Business area of the company

The company is one of the leading specialty chemicals manufacturing companies in India providing customized solutions to specific industrial and production requirements of its customers primarily in the FMCG, apparel, poultry and animal feed industries through its diversified product portfolio comprising home, personal care and performance chemicals; textile specialty chemicals; and animal health and nutrition products. The company’s business is organized in three main product categories - (i) home, personal care and performance chemicals; (ii) textile specialty chemicals; and (iii) animal health and nutrition products.

The company is the leading manufacturer of acrylic polymers in India and manufactures many products for its customers in the soaps and detergent, paints, inks and coatings, ceramics and tiles, water treatment chemicals and pulp and paper industries. It also manufacture institutional cleaning chemical formulations for hospitality, facility management, airports, corporates, food service, commercial laundry, malls, multiplexes, educational sector, places of worship etc. It is in advanced stages of expanding its home, personal care and performance product portfolio to water treatment formulations, specialty formulation for breweries as well as dairies. Besides, the company provides specialty chemicals for the entire value-chain of the textile industry starting from fiber, yarn to fabric, wet processing and garment processing. The company has also diversified into animal health and nutrition and currently supply poultry feed supplements and additives, pet grooming and pet treats including for weaning, infants and adult pets.

Major Events & Milestones:

  • 2003: The company’s Promoters entered into a partnership firm to start the manufacturers of specialty chemicals and industrial enzymes in India.
  • 2004: Established first manufacturing facility at Silvassa.
  • 2009: Conversion of partnership firm into company.
  • 2009: Incorporation of company.
  • 2009: Obtained recognition for in-house R&D unit from the Department of Scientific and Industrial Research.
  • 2010: Forayed into animal health and nutrition products.
  • 2013: Forayed into HPPC products.
  • 2014: The company’s Promoters entered into a Joint Venture with BUZIL-WERK Wagner GmbH & Co. KG to form Buzil Rossari.
  • 2015: Lease granted by GIDC to company for setting up manufacturing facility at Dahej.
  • 2017: The Food Safety Management System of Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 9001:2015.
  • 2018: Entered into an exclusive purchasing agreement with Hindustan Unilever.
  • 2020: Completion of the Pre-IPO Placement.

Awards & accreditations:

  • 2009: The erstwhile Hon’ble Union Finance Minister Pranab Mukherjee awarded ‘Corp EXCEL 2008– National mSME’ form a list of 27000 companies.
  • 2010: Frost & Sullivan awarded ‘Customer Value Enhancement for Industrial Enzymes Market’.
  • 2011: The Council for Fair Business Practices awarded ‘CFBP – Jamnalal Bajaj Uchit Vyavahar Puraskar for Fair Business Practices’.
  • 2017: The India SME Forum awarded at the India SME 100 Awards for ‘scoring in the top 100 in the overall evaluation of Financial & Non - Financial Parameters amongst 33102 nominations’.
  • 2018: Arvind awarded ‘Star Performer Award 2018’ in the Dye & Chemicals Category.
You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×